Genmab A/S (GE9.F)
EUR 174.9
(3.49%)
EUR 174.9
(3.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 989.73 Million | 524.52 Million | 299.58 Million | 864.24 Million | 177.45 Million | 135.98 Million |
| Net Income | 583.64 Million | 731 Million | 404.46 Million | 639.21 Million | 289.86 Million | 197.27 Million |
| Depreciation & Amortization | 43.85 Million | 38.88 Million | 33.61 Million | 33.04 Million | 18.6 Million | 11.75 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 182.65 Million | -246.7 Million | -103.53 Million | 132.59 Million | -162.99 Million | -85 Million |
| Other non-cash items | 84.62 Million | 325.81 Million | 135.8 Million | 61.79 Million | 232.18 Million | 120.48 Million |
| Investing Cash Flow | -171.92 Million | -370.19 Million | -129.21 Million | -315.84 Million | -265.37 Million | -238.2 Million |
| Investments in PPE | -50.42 Million | -42.5 Million | -33.88 Million | -41.24 Million | -14.85 Million | -63.96 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -1.46 Billion | -1.3 Billion | -2.09 Billion | -1.66 Billion | -777.78 Million | -471.85 Million |
| Sales/Maturities of investments | 1.34 Billion | 972.62 Million | 2 Billion | 1.39 Billion | 527.26 Million | 297.62 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -81.27 Million | -105.78 Million | -56.47 Million | 9.53 Million | 489.79 Million | -9.5 Million |
| Debt repayment | - | - | - | - | -4.14 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -75.63 Million | -121.74 Million | -60.1 Million | - | - | -19.58 Million |
| Common Stock Issuance | 20.38 Million | 37.54 Million | 18.15 Million | 18.8 Million | 495.15 Million | 10.08 Million |
| Other Financing Activities | -13.81 Million | -11.79 Million | -6.72 Million | -3.35 Million | -1.2 Million | - |
| Accounts receivables | 106.88 Million | -284.65 Million | -144.41 Million | 41.1 Million | -221.88 Million | -102.93 Million |
| Accounts payables | 83.41 Million | 37.94 Million | 40.87 Million | 22.57 Million | 58.88 Million | 17.92 Million |
| Inventory | -7.64 Million | - | - | - | - | - |
| Other working capital | - | - | - | 68.91 Million | - | - |
| Cash at beginning of period | 1.32 Billion | 1.2 Billion | 975.35 Million | 475.34 Million | 71.41 Million | 180.98 Million |
| Cash at end of period | 1.99 Billion | 1.32 Billion | 1.2 Billion | 975.35 Million | 475.34 Million | 71.41 Million |
| Capital Expenditure | -50.42 Million | -42.5 Million | -33.88 Million | -41.24 Million | -14.85 Million | -63.96 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 667.35 Million | 122.07 Million | 229.03 Million | 500 Million | 403.93 Million | -109.57 Million |
| Free Cash Flow | 939.3 Million | 482.02 Million | 265.69 Million | 823 Million | 162.59 Million | 72.01 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 188.36 Million | 177.19 Million | 85.83 Million | 583.64 Million | 284.78 Million | 181.76 Million |
| Depreciation & Amortization | - | - | - | 43.85 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -92.17 Million | 56.03 Million | 21.18 Million | 182.65 Million | -18.32 Million | -200.38 Million |
| Other non-cash items | 106.22 Million | -30.89 Million | 117.21 Million | 84.62 Million | 6.01 Million | 77.01 Million |
| Investing Cash Flow | -1.17 Billion | -192.71 Million | -59.27 Million | -171.92 Million | 134.83 Million | -245.79 Million |
| Investments in PPE | -3.61 Million | -3.74 Million | -8.98 Million | -50.42 Million | -13.1 Million | -14.33 Million |
| Acquisitions | -1.63 Billion | - | - | - | - | - |
| Investment purchases | -95.79 Million | -609.02 Million | -336.34 Million | -1.46 Billion | -170.14 Million | -569.4 Million |
| Sales/Maturities of investments | 574.74 Million | 420.06 Million | 286.05 Million | 1.34 Billion | 318.08 Million | 337.94 Million |
| Other Investing Activities | -10.56 Million | - | - | - | - | - |
| Financing Cash Flow | -408.17 Million | -79.57 Million | -2.95 Million | -81.27 Million | 2.67 Million | 937.62 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -406.7 Million | -72.88 Million | - | -75.63 Million | - | -2.81 Million |
| Common Stock Issuance | 2.14 Million | 7.89 Million | 1.2 Million | 20.38 Million | 5.35 Million | 9.51 Million |
| Other Financing Activities | -1.07 Million | -11.36 Million | -804.66 Thousand | -13.81 Million | -535.05 Thousand | -1.87 Million |
| Accounts receivables | - | - | - | 106.88 Million | - | - |
| Accounts payables | - | - | - | 83.41 Million | - | - |
| Inventory | - | - | - | -7.64 Million | - | - |
| Other working capital | -56.05 Million | 56.03 Million | -161.46 Million | - | -18.32 Million | -200.38 Million |
| Cash at beginning of period | 1.96 Billion | 1.99 Billion | 1.9 Billion | 1.32 Billion | 1.45 Billion | 1.64 Billion |
| Cash at end of period | 579.42 Million | 1.96 Billion | 1.99 Billion | 1.99 Billion | 1.9 Billion | 1.45 Billion |
| Capital Expenditure | -3.61 Million | -3.74 Million | -8.98 Million | -50.42 Million | -13.1 Million | -14.33 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.38 Billion | -31.92 Million | 84.61 Million | 667.35 Million | 452.67 Million | -189.71 Million |
| Free Cash Flow | 198.8 Million | 198.59 Million | 215.24 Million | 939.3 Million | 259.36 Million | 44.06 Million |
2029
CVC
SPT
ALGLD
MENONBE
DIGIDRIVE